christy_nolandweb

Astellas appoints comms head from Baxter

pharmafile | September 18, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris 

Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in the Americas.

Noland will report directly to Margaret Long who is the vice president of business communications and advocacy for the US pharma firm. She joins Astellas from Baxter International where she was a director of communications for its renal business.

Prior to that Noland worked at several PR agencies: including GolinHarris, Burson-Marsteller and Edelman, where her clients ranged from large pharma companies to patient and doctor advocacy groups.

Advertisement

In her new role Noland will be responsible for communicating Astellas’ commitment to urology to patient and advocacy organisations, as well as collaborating with the urology brand teams on strategic initiatives. Noland’s appointment adds to the firm’s formation of a new corporate comms team under the leadership of Jeff Winton, senior VP, chief communications officer.  

“Christy has an outstanding reputation in the business and we’re thrilled to bring her onto our growing team,” says Long. “Her experience working in both the pharmaceutical industry and the patient advocacy community has provided Christy valuable insights that will help drive the goals of the urology team and the patients we serve.”

Related Content

Baxter expands US portfolio with new injectables

Baxter International has announced the continued expansion of its pharmaceuticals portfolio with the launch of …

Astellas and Elpiscience enter collaboration for novel bispecific macrophage engager

Elpiscience Biopharma and Astellas Pharma have announced that they have entered into a research collaboration …

Chemotherapy

EMA accepts Astellas’ MAA for Zolbetuximab

Astellas Pharma has announced that the European Medicines Agency (EMA) has accepted the company’s marketing …

The Gateway to Local Adoption Series

Latest content